Title: Combination of Neutrophil/Lymphocyte Ratio and Albumin/Bilirubin Grade as a
Prognostic Predictor for Hepatocellular Carcinoma Patients Undergoing Curative Hepatectomy
Version: 2 Date: 07 Mar 2023
Reviewer's report:
The authors explored some common inflammation-related markers vut there are also other
markers, for example lymphocyte/monocyte ratio. Could the authors comment on this?
How did the authors validated the model? The authors could try an internal validation (the
authors could at least comment and cite an example of this validation like in the paper PMID:
27005802)
How the cut-off for these values were chosen?
Title: Combination of Neutrophil/Lymphocyte Ratio and Albumin/Bilirubin Grade as a
Prognostic Predictor for Hepatocellular Carcinoma Patients Undergoing Curative Hepatectomy
Version: 2 Date: 07 Mar 2023
Reviewer's report:
The authors explored some common inflammation-related markers vut there are also other
markers, for example lymphocyte/monocyte ratio. Could the authors comment on this?
How did the authors validated the model? The authors could try an internal validation (the
authors could at least comment and cite an example of this validation like in the paper PMID:
27005802)
How the cut-off for these values were chosen?
Please review this paper.
user
Title: Combination of Neutrophil/Lymphocyte Ratio and Albumin/Bilirubin Grade as a
Prognostic Predictor for Hepatocellular Carcinoma Patients Undergoing Curative Hepatectomy
Version: 2 Date: 07 Mar 2023
Reviewer's report:
The authors explored some common inflammation-related markers vut there are also other
markers, for example lymphocyte/monocyte ratio. Could the authors comment on this?
How did the authors validated the model? The authors could try an internal validation (the
authors could at least comment and cite an example of this validation like in the paper PMID:
27005802)
How the cut-off for these values were chosen?
assistant